Valuation: Control Bionics Limited

Market Cap 2.66Cr 1.85Cr 1.66Cr 1.52Cr 1.38Cr 2.6Cr 175.69Cr 18Cr 7.31Cr 93Cr 6.96Cr 6.81Cr 293.92Cr P/E 2025
-1.3x
P/E 2026 -3.78x
Enterprise Value 2.51Cr 1.75Cr 1.56Cr 1.43Cr 1.3Cr 2.45Cr 165.55Cr 17Cr 6.89Cr 87Cr 6.56Cr 6.42Cr 276.95Cr EV / Sales 2025
1.4x
EV / Sales 2026 6.07x
Free-Float
73.2%
Yield 2025 *
-
Yield 2026 -
1 day-2.00%
1 week-7.55%
Current month-5.77%
1 month-19.67%
3 months-23.44%
6 months-12.50%
Current year-19.67%
1 week 0.05
Extreme 0.048
0.05
1 month 0.05
Extreme 0.048
0.07
Current year 0.05
Extreme 0.048
0.1
1 year 0.04
Extreme 0.037
0.1
3 years 0.03
Extreme 0.026
0.1
5 years 0.03
Extreme 0.026
0.54
10 years 0.03
Extreme 0.026
1.24
Manager TitleAgeSince
Chief Executive Officer - 19/01/2023
Director of Finance/CFO - 13/05/2024
Chief Tech/Sci/R&D Officer - 01/01/2014
Director TitleAgeSince
Chairman 66 19/11/2025
Director/Board Member - 19/01/2023
Director/Board Member - 01/04/2023
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-7.55%+44.12%-7.55% 1.91Cr
+2.30%+1.96%+23.08%+56.03% 25TCr
+0.94%-1.23%+6.84%+19.24% 16TCr
+0.89%-2.41%-17.51%+58.61% 15TCr
-1.85%-4.56%-56.81%-17.17% 6.42TCr
-0.12%+2.51%-10.75%-8.53% 5.41TCr
+2.07%+5.11%+15.45%+45.26% 5.38TCr
-1.23%-4.70%+4.12%+59.66% 4.97TCr
+2.02%-0.28%+19.88%+67.95% 4.85TCr
+2.31%+0.86%+31.55%+87.40% 4.42TCr
Average +0.62%-1.25%+6.00%+36.09% 8.79TCr
Weighted average by Cap. +1.29%-0.75%+3.92%+42.22%

Financials

2025 2026
Net sales 61.45L 42.83L 38.26L 35.15L 31.92L 59.94L 41Cr 4.2Cr 1.69Cr 21Cr 1.61Cr 1.57Cr 68Cr 47.67L 33.22L 29.68L 27.26L 24.76L 46.5L 31Cr 3.25Cr 1.31Cr 17Cr 1.25Cr 1.22Cr 53Cr
Net income -61.09L -42.58L -38.04L -34.94L -31.73L -59.59L -40Cr -4.17Cr -1.68Cr -21Cr -1.6Cr -1.56Cr -67Cr -72.66L -50.64L -45.24L -41.56L -37.74L -70.88L -48Cr -4.96Cr -2Cr -25Cr -1.9Cr -1.86Cr -80Cr
Net Debt -2L -2L -1L -1L -1L -2L -1.57Cr -16.2L -7L -82.68L -6L -6L -2.62Cr -15.36L -10.7L -10L -9L -8L -14.98L -10Cr -1.05Cr -42.18L -5.35Cr -40.18L -39.32L -17Cr
Projected Income Statement - Annual - Control Bionics Limited
Logo Control Bionics Limited
Control Bionics Limited is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses, such as Motor Neurone Disease and Amyotrophic Lateral Sclerosis. Its products include Control Bionics Trilogy Systems, NeuroStrip, NeuroNode, Cosmos Connect and accessories. NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as electromyography output. This output is then sent wirelessly via NeuroNode to a personal computer, enabling speech and other computer-controlled functions like email and texting. Its technology is integrated with eye gaze technology whereby the eye gaze enables a cursor to be moved about a computer screen, driven much like a mouse and the NeuroNode acts like a mouse button. It is commercializing its advancement in its technology, NeuroStrip. It is focused on neuromuscular rehabilitation and athletic optimization.
Employees
-
Date Price Change Volume
03/26/03 A$0.0490 -2.00% 2,10,714
02/26/02 A$0.0500 -3.85% 6,94,001
30/26/30 A$0.0520 +6.12% 2,40,667
29/26/29 A$0.0490 0.00% 13,71,182
28/26/28 A$0.0490 -7.55% 22,78,967